These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 5230213)
41. [Clinico-biochemical and genetic studies of myopathy]. Davidenkova EF; Droznina TA; Markelov IM Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(11):1623-8. PubMed ID: 6001049 [No Abstract] [Full Text] [Related]
43. The age-dependent decrease in creatine kinase and aldolase activities in human striated muscle is not caused by an accumulation of faulty proteins. Steinhagen-Thiessen E; Hilz H Mech Ageing Dev; 1976; 5(6):447-57. PubMed ID: 994563 [TBL] [Abstract][Full Text] [Related]
44. Muscle adenylic acid deaminase activity. Selective decrease in early-onset Duchenne muscular dystrophy. Kar NC; Pearson CM Neurology; 1973 May; 23(5):478-82. PubMed ID: 4735464 [No Abstract] [Full Text] [Related]
45. Skin Biopsy for Diagnosis of Ullrich Congenital Muscular Dystrophy: An Observational Study. Chakrabarty B; Sharma MC; Gulati S; Sarkar C J Child Neurol; 2017 Dec; 32(14):1099-1103. PubMed ID: 29129153 [TBL] [Abstract][Full Text] [Related]
50. Development and specialization in muscle and the biochemistry of the dystrophies. Perry SV J Neurol Sci; 1971 Mar; 12(3):289-306. PubMed ID: 5550262 [No Abstract] [Full Text] [Related]
51. Trophic functions of the neuron. IV. Clinical disorders of trophic function: muscular dystrophy? Are the muscular dystrophies neurogenic? Rowland LP Ann N Y Acad Sci; 1974 Mar; 228(0):244-60. PubMed ID: 4526279 [No Abstract] [Full Text] [Related]
52. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy]. Radu H; Keresztes L; Stenzel K Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841 [No Abstract] [Full Text] [Related]
53. [Myocardial and muscular aldolase activity in a strain of hereditary myodystrophic mice]. MAGGI V; SENSI S; MAGARO M; GRECO AV; GAMBASSI G Boll Soc Ital Biol Sper; 1959 Jul; 35():882-3. PubMed ID: 14419823 [No Abstract] [Full Text] [Related]
54. Protein metabolism in Duchenne muscular dystrophy, monoclonal and mixed skeletal muscle cultures. Corbett AJ Clin Exp Neurol; 1987; 24():214-9. PubMed ID: 3268348 [TBL] [Abstract][Full Text] [Related]
55. [Comparative study of the enzyme activity of muscle tissue of normal children and children with progressive muscular dystrophy at different stages of the disease]. Hooft C; De Laey P; Lambert Y Rev Fr Etud Clin Biol; 1966 May; 11(5):510-1. PubMed ID: 5938397 [No Abstract] [Full Text] [Related]
56. Serum ATP: creatine phosphotransferase in skeleto-muscular disorders with special reference to duchenne muscular dystrophy. Griffiths PD Guys Hosp Rep; 1965; 114(4):401-20. PubMed ID: 5859368 [No Abstract] [Full Text] [Related]
57. DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF SERUM ENZYMES. I. MUSCULAR DYSTROPHY. FOWLER WM Arch Phys Med Rehabil; 1964 Mar; 45():117-24. PubMed ID: 14127953 [No Abstract] [Full Text] [Related]
58. Biochemical, histological and electron microscopical study of experimentally induced cortisone myopathy. Luca N; Hategan D; Anghelescu N; Alexianu M; Petrovici A Neurol Psychiatr (Bucur); 1977; 15(1):57-63. PubMed ID: 877496 [No Abstract] [Full Text] [Related]
59. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)]. Ceccarelli A; Leone P; Moretti A Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288 [No Abstract] [Full Text] [Related]